In vivo data show Evusheld retains neutralizing activity against Omicron SARS-CoV-2 BA.2 subvariant March 22, 2022
Chongqing Medical University compounds inhibit GST isozyme Mu, sensitize tumors to cisplatin in vivo March 22, 2022
PKMYT1 inhibitor RP-6306 for the treatment of aberrant DNA damage repair-driven cancers March 22, 2022
Ixaka expands IP portfolio to allow use of TNP gene delivery platform across multiple areas March 21, 2022
RSS